-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Administer indigovirus
The HSE reviewed indaterol's approval process based on new scientific information indicating that the active substance may no longer meet the approval criteria
.
.
The review covered the impact of indine's new toxicological reference values on the risk assessment, as well as input from manufacturers and authorised holders
.
.
The study found that non-dietary exposure for a variety of representative uses exceeded the acceptable range for operators, workers, residents, and passers-by
.
The HSE therefore recommends the revocation of indiivir's approval
in the United Kingdom (GB).
.
The HSE therefore recommends the revocation of indiivir's approval
in the United Kingdom (GB).
The specific details of this proposal will be submitted to the World Trade Organization (WTO) for comments
from trading partners.
from trading partners.
Further information and progress on indievir approval will be recorded in the statutory approval register for the active substance
.
.